Literature DB >> 1272636

Morphologic studies in a patient with homocystinuria due to 5, 10-methylenetetrahydrofolate reductase deficiency.

Y S Kanwar, J R Manaligod, P W Wong.   

Abstract

Biochemical and morphologic studies on a patient with homocystinuria due to a deficiency of 5, 10-methylenetetrahydrofolate reductase (EC. 1.1.1.68) were performed. The concentrations of homocystine in the patient's plasma and urine were 2.97 mumol/dl and 44.67 mumol/24 hr, respectively. Activities of 5, 10-methylenetetrahydrofolate reductase (expressed as nanomoles of formaldehyde formed per hr per mg of protein) in cultured skin fibroblasts and liver tissue were 0.53 (control: 5.14) and 0.00 (control: 13.80), respectively. The major abnormalities were found in the arterial bed, consisting of intimal hyperplasia, fragmentation, and disruption of elastic lamellae and subcellular changes in the endothelial cells. Extensive thrombosis was observed. The brain and the liver also showed widespread pathologic changes. In the former, neuronal loss and cellular damage were prominent and extensive. Diffuse demyelination with moderate astrocytosis was found; but demyelination was out of proportion to the vascular changes. Hirano bodies in the cortical neurons and crystalline and lamellar bodies in the Purkinje cells were observed. In the liver, there were fatty change and mild to moderate portal fibrosis. Bizarre, giant mitochondria and membrane-bound multivesicular bodies were found. Mild pathologic changes were also observed in the striated muscles and the kidneys. Focal fragmentation, disruption, and smearing of the Z discs and disorganization of the myofilaments were found in the skeletal muscles. The kidneys showed shrunken glomeruli, thickened basement membranes, and swelling of epithelial as well as endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1272636     DOI: 10.1203/00006450-197606000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  18 in total

1.  The effect of a subnormal vitamin B-6 status on homocysteine metabolism.

Authors:  J B Ubbink; A van der Merwe; R Delport; R H Allen; S P Stabler; R Riezler; W J Vermaak
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury.

Authors:  Avisek Majumder; Mahavir Singh; Jyotirmaya Behera; Nicholas T Theilen; Akash K George; Neetu Tyagi; Naira Metreveli; Suresh C Tyagi
Journal:  Am J Physiol Cell Physiol       Date:  2018-08-15       Impact factor: 4.249

Review 3.  Hyperhomocysteinaemia; with reference to its neuroradiological aspects.

Authors:  M van den Berg; M S van der Knaap; G H Boers; C D Stehouwer; J A Rauwerda; J Valk
Journal:  Neuroradiology       Date:  1995-07       Impact factor: 2.804

4.  Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency.

Authors:  U Wendel; H J Bremer
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

5.  Decreased rates of methionine synthesis by methylene tetrahydrofolate reductase-deficient fibroblasts and lymphoblasts.

Authors:  G R Boss; R W Erbe
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

6.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.

Authors:  S S Kang; J Zhou; P W Wong; J Kowalisyn; G Strokosch
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

7.  Folate distribution in cultured human cells. Studies on 5,10-CH2-H4PteGlu reductase deficiency.

Authors:  D S Rosenblatt; B A Cooper; S Lue-Shing; P W Wong; S Berlow; K Narisawa; R Baumgartner
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

Review 8.  Hydrogen sulfide pathway and skeletal muscle: an introductory review.

Authors:  Valentina Vellecco; Chiara Armogida; Mariarosaria Bucci
Journal:  Br J Pharmacol       Date:  2018-06-15       Impact factor: 8.739

9.  A study of cardiovascular risk in heterozygotes for homocystinuria.

Authors:  S H Mudd; R Havlik; H L Levy; V A McKusick; M Feinleib
Journal:  Am J Hum Genet       Date:  1981-11       Impact factor: 11.025

10.  Subacute combined degeneration of the cord, dementia and parkinsonism due to an inborn error of folate metabolism.

Authors:  P T Clayton; I Smith; B Harding; K Hyland; J V Leonard; R J Leeming
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.